A leading U.S-based diversified pharmaceutical and Life Sciences company was challenged to improve relationships with strategic suppliers and contract manufacturers. In the face of increasing market pressure over source materials, the client asked for Archstone's support in improving overall visibility through their global supply chain, especially from overseas suppliers.
A leading U.S.-based diversified pharmaceutical and Life Sciences company.
To develop the SRM program, Archstone first reviewed supplier feedback, stakeholder requirements, and existing resources to help define the stratification process and to strategically refocus resources. Part of this approach included designing governance processes and a supplier development program as well as defining training requirements and a communication plan to support implementation.
The multi-wave pilot program was implemented across key CM's and raw material suppliers. In particular, under this new process, the client was able to improve risk management results with a key strategic contract manufacturer -- identifying and resolving a potential quality problem. The overall raw material supplier base was reduced by 30%.